86 related articles for article (PubMed ID: 1516336)
1. Thrombolysis in high risk patients.
McCall J; Gleeson FV; McGann G; Dawson K; Platts AD; Hamilton G
Clin Radiol; 1992 May; 45(5):298-301. PubMed ID: 1516336
[TBL] [Abstract][Full Text] [Related]
2. Re: "Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique". Thrombolysis Study Group.
Braithwaite BD
J Vasc Surg; 1995 Mar; 21(3):540. PubMed ID: 7877240
[No Abstract] [Full Text] [Related]
3. Peripheral thrombolysis with tissue plasminogen activator. Results of two treatment regimens.
Ward AS; Andaz SK; Bygrave S
Arch Surg; 1994 Aug; 129(8):861-5. PubMed ID: 8048859
[TBL] [Abstract][Full Text] [Related]
4. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
[TBL] [Abstract][Full Text] [Related]
5. [Local thrombolysis in the treatment of peripheral arterial vascular diseases].
Mikita J; Ilonczai P; Tóth J
Orv Hetil; 2007 Sep; 148(37):1737-44. PubMed ID: 17827082
[TBL] [Abstract][Full Text] [Related]
6. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
Ouriel K; Kandarpa K
J Endovasc Ther; 2004 Aug; 11(4):436-46. PubMed ID: 15298504
[TBL] [Abstract][Full Text] [Related]
7. Catheter-directed pharmacologic thrombolysis for acute pulmonary embolism immediately following lung transplantation.
Reddick M; Pillai AK; Bollineni S; Kalva S
J Vasc Interv Radiol; 2015 Jan; 26(1):142-4. PubMed ID: 25541455
[No Abstract] [Full Text] [Related]
8. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
9. Safety of intra-arterial thrombolysis in the postoperative period.
Chalela JA; Katzan I; Liebeskind DS; Rasmussen P; Zaidat O; Suarez JI; Chiu D; Klucznick RP; Jauch E; Cucchiara BL; Saver J; Kasner SE
Stroke; 2001 Jun; 32(6):1365-9. PubMed ID: 11387500
[TBL] [Abstract][Full Text] [Related]
10. Low-dose intra-arterial thrombolysis in the treatment of occluded vascular grafts.
Browse DJ; Torrie EP; Galland RB
Br J Surg; 1992 Jan; 79(1):86-8. PubMed ID: 1737288
[TBL] [Abstract][Full Text] [Related]
11. A simplified procedure for intra-arterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results.
Decrinis M; Pilger E; Stark G; Lafer M; Obernosterer A; Lammer J
Eur Heart J; 1993 Mar; 14(3):297-305. PubMed ID: 8458348
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis of prosthetic tricuspid valve thrombosis with human recombinant tissue plasminogen activator in an adolescent.
Bolz D; Kühne T; Jivraj R; Hammer J
Pediatr Cardiol; 2000; 21(4):397-400. PubMed ID: 10865025
[TBL] [Abstract][Full Text] [Related]
13. [Arterial thrombolysis in the lower extremity in vascular surgical practice].
Entz L; Laczkó A; Bíró G; Széphelyi K; Simonffy A; Járányi Z
Magy Seb; 2007 Jan; 60(1):501-5. PubMed ID: 17474303
[TBL] [Abstract][Full Text] [Related]
14. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828
[TBL] [Abstract][Full Text] [Related]
15. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.
Ann Surg; 1994 Sep; 220(3):251-66; discussion 266-8. PubMed ID: 8092895
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy in peripheral arterial occlusive disease: mechanisms of action and drugs available.
Comerota AJ; Cohen GS
Can J Surg; 1993 Aug; 36(4):342-8. PubMed ID: 8370015
[TBL] [Abstract][Full Text] [Related]
17. Peripheral thrombolysis for acute-onset claudication. Thrombolysis Study Group.
Braithwaite BD; Tomlinson MA; Walker SR; Davies B; Buckenham TM; Earnshaw JJ
Br J Surg; 1999 Jun; 86(6):800-4. PubMed ID: 10383582
[TBL] [Abstract][Full Text] [Related]
18. Reteplase: nursing implications for catheter-directed thrombolytic therapy for peripheral vascular occlusions.
Bussard ME
Crit Care Nurse; 2002 Jun; 22(3):57-63. PubMed ID: 12092294
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization.
Tsetis DK; Kochiadakis GE; Hatzidakis AA; Skalidis EI; Chryssou EG; Tritou IN; Vardas PE; Gourtsoyiannis NC
Cardiovasc Intervent Radiol; 2002; 25(1):36-41. PubMed ID: 11907772
[TBL] [Abstract][Full Text] [Related]
20. Successful thrombolysis for massive pulmonary embolism after pulmonary resection.
Sayeed RA; Nashef SA
Ann Thorac Surg; 1999 Jun; 67(6):1785-7. PubMed ID: 10391296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
